Prevalence of estrogen receptor variant messenger RNAs in human breast cancer

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4324-4327

  Leygue, Etienne ^a   Huang, Aihua ^a   Murphy, Leigh C ^a   Watson, Peter H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; TUMOR GROWTH;

BREAST NEOPLASMS; EXONS; FEMALE; HUMANS; MUTATION; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PREVALENCE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE DELETION;

EID: 0029738763     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Murphy, L C., and Dotzlaw, H Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples Mol. Endocrinol., 3: 687-693, 1989.
2. McGuire, W. L., Chamness, G C., and Fuqua, S A. W Estrogen receptor variants in clinical breast cancer Mol Endocrinol., 5: 1571-1577, 1991.
3. Wang, Y., and Miksicek, R J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol., 5: 1707-1715, 1991.
4. Fuqua, S. A W., Fitzgerald, S. D., Chamness, G. C., Tandon, A K, McDonnell, D P, Nawaz, Z, O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity Cancer Res., 51: 105-109, 1991.
5. Dotzlaw, H, Alkhalaf, M, and Murphy, L C Characterization of estrogen receptor variant mRNAs from human breast cancers Mol. Endocrinol., 6: 773-785, 1992.
6. Fuqua, S A. W., Fitzgerald, S D., Allred, D C, Elledge, R. M., Nawaz, Z., McDonnell, D P., O'Malley, B W, Greene, G. L., and McGuire, W. L. Inhibition of estrogen receptor activity by a naturally occurring variant in human breast tumors. Cancer Res., 52, 483-486, 1992
7. Pfeffer, U., Fecarotta, E., Castagnetta, E., and Vidali, G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res., 53: 741-743, 1993
8. Pfeffer, U., Fecarotta, E., and Vidali, G Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells Cancer Res, 55: 2158-2165, 1995.
9. Gotteland, M., Desauty, G, Delarue, J. C, Liu, L., and May, E. Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol. Cell. Endocrinol., 112: 1-13, 1995.
10. Murphy, L. C, Wang, M, Coutt, A, and Dotzlaw, H. Novel mutations in the estrogen receptor messenger RNA in human breast cancer J. Clin. Endocrinol. Metab., 181: 1420-1427, 1996
11. Leygue, E, Watson, P H., and Murphy, L C. Estrogen receptor variants in normal human mammary tissue J. Natl. Cancer Inst, 88: 284-290, 1996.
12. Kumar, V., Green, S., Stack, G., Berry, M, Jin, J. R., and Chambon, P Functional domains of the human estrogen receptor Cell, 51 941-951, 1987.
13. Castles, C. G, Fuqua, S A. W., Klotz, D. M, and Hill, S. M. Expression of a constitutively active estrogen receptor variant in the estrogen-receptor negative BT-20 human breast cancer cell line. Cancer Res., 53, 5934-5939, 1993.
14. Sluyser, M Role of estrogen receptor variants in the development of hormone resistance in breast cancer Clin. Biochem., 25: 407-414, 1992.
15. Horwitz, K. B. How do breast cancers become hormone resistant? J. Steroid Biochem. Mol. Biol., 49: 295-302, 1994.
16. Daffada, A. A. I, Johnston, S. R D., Nicholls, J., and Dowsett, M. Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J. Mol Endocrinol, 13: 265-273, 1994
17. Madsen, M. W., Reiter, B. E, and Lykkesfeldt, A. E Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TamR-1 compared to the parental MCF-7 cell line. Mol. Cell. Endocrinol., 109:197-207, 1995
18. Murphy, L. C., Hilsenbeck, S. G., Dotzlaw, H., and Fuqua, S. A W. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Clin. Cancer Res, 1: 155-159, 1995.
19. Klotz, D M, Castles, C. G, Fuqua, S A W., Spriggs, L L, and Hill, S M. Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 cancer cells may account for differences in estrogen responsiveness. Biochem. Biophys. Res. Commun. 210 609-615, 1995
20. Leygue, E., Murphy, L C. Kuttenn, F, and Watson, P. H Triple primer PCR a new way to quantify truncated mRNA expression. Am J Pathol., 148: 1097-1103, 1996
21. Elston, C. W. and Ellis, I O. Pathological prognostic factors in breast cancer Histopathology. 19: 403-410, 1991.
22. Green, S, Walter, P. Kumar, V., Krust, A., Bornert, J. M, Argos, P., and Chambon, P. Human oestrogen receptor cDNA sequence, expression and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.
23. Sluyser, M Mutations in the estrogen receptor genes Hum Mutat., 6: 97-103, 1995
24. Daffada, A A. I., and Dowsett, M. Tissue dependent expression of a novel splice variant of the human oestrogen receptor. J Steroid Biochem. Mol. Biol, 55: 413-421, 1995.